标题
New therapeutic solutions for Behçet’s syndrome
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 7, Pages 827-840
出版商
Informa UK Limited
发表日期
2016-05-11
DOI
10.1080/13543784.2016.1181751
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens
- (2016) L. Cantarini et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Safety and Efficacy of Gevokizumab in Patients with Behçet’s Disease Uveitis: Results of an Exploratory Phase 2 Study
- (2016) Ilknur Tugal-Tutkun et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease
- (2015) Luca Cantarini et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
- (2015) C. Paul et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study
- (2015) Giacomo Emmi et al. CLINICAL RHEUMATOLOGY
- Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection
- (2015) Antonio Vitale et al. International Journal of Rheumatic Diseases
- Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study
- (2015) Luca Cantarini et al. International Journal of Rheumatic Diseases
- Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients
- (2015) H. Vallet et al. JOURNAL OF AUTOIMMUNITY
- Alemtuzumab as Remission Induction Therapy in Behcet Disease: A 20-year Experience
- (2015) A. J. Mohammad et al. JOURNAL OF RHEUMATOLOGY
- Mucocutaneous Involvement in Behçet’s Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives
- (2015) Cinzia Rotondo et al. MEDIATORS OF INFLAMMATION
- Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives
- (2015) Giuseppe Lopalco et al. MEDIATORS OF INFLAMMATION
- Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcetʼs Disease
- (2015) Giuseppe Lopalco et al. MEDICINE
- Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study
- (2015) Gulen Hatemi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successful treatment with canakinumab of a paediatric patient with resistant Behçet’s disease
- (2015) Ilaria Pagnini et al. RHEUMATOLOGY
- Tocilizumab for severe refractory neuro-Behçet: Three cases IL-6 blockade in neuro-Behçet
- (2015) Olga Addimanda et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Pathogenesis of Behçet’s disease: autoinflammatory features and beyond
- (2015) Ahmet Gül Seminars in Immunopathology
- The hereditary autoinflammatory disorders uncovered
- (2014) Donato Rigante et al. AUTOIMMUNITY REVIEWS
- Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab
- (2014) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series
- (2014) Antonio Vitale et al. DERMATOLOGY
- Anti-interferon alpha antibodies and autoantibodies in patients with Behçet’s disease uveitis treated with recombinant human interferon alpha-2a
- (2014) Özlem Aydinoglu-Candan et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future
- (2014) Luca Cantarini et al. IMMUNOLOGIC RESEARCH
- Treatment of retinal vasculitis in Behçet's disease with rituximab
- (2014) Shahram Sadreddini et al. Modern Rheumatology
- A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab
- (2014) Toru Hirano et al. Modern Rheumatology
- Bone marrow transplantation for Behcet's disease: a case report and systematic review of the literature
- (2014) T. Soysal et al. RHEUMATOLOGY
- Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation
- (2014) Min-Ha Kook et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Resistant Behçet Disease Responsive to Anakinra
- (2013) Costantino Botsios et al. ANNALS OF INTERNAL MEDICINE
- Phosphodiesterase 4-targeted treatments for autoimmune diseases
- (2013) Neal Kumar et al. BMC Medicine
- Improved clinical control of a challenging case of Behçet’s disease with rituximab therapy
- (2013) Barbara Hong Zhao et al. CLINICAL RHEUMATOLOGY
- Anakinra treatment in drug-resistant Behcet’s disease: a case series
- (2013) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab
- (2013) Francesco Caso et al. IMMUNOLOGIC RESEARCH
- Impact of alemtuzumab treatment on the survival and function of human regulatory T cellsin vitro
- (2013) Evis Havari et al. IMMUNOLOGY
- Successful treatment by azacitidine therapy of intestinal Behçet’s disease associated with myelodysplastic syndrome
- (2013) Hiroaki Tanaka et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet's disease retinal vasculitis: report of three patients
- (2013) Fereydoun Davatchi et al. International Journal of Rheumatic Diseases
- Remission Induction in a Case of Refractory Behçet Disease With Alemtuzumab
- (2013) Eva Perez-Pampin et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Experiences with Rituximab for the Treatment of Autoimmune Diseases with Ocular Involvement
- (2013) L. Pelegrin et al. JOURNAL OF RHEUMATOLOGY
- Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials
- (2013) Andrew D. Dick et al. OPHTHALMOLOGY
- Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcet’s Disease
- (2013) M.D. Redondo-Pachón et al. RENAL FAILURE
- Behçet's Syndrome
- (2013) Gulen Hatemi et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Lack of efficacy of tocilizumab in mucocutaneous Behçet’s syndrome: report of two cases
- (2013) Andreas P. Diamantopoulos et al. RHEUMATOLOGY
- Optimal use of ivig in a patient with Behçet syndrome and common variable immunodeficiency
- (2012) Brandon Shutty et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Successful long-term triple disease control by ustekinumab in a patient with Behçet's disease, psoriasis and hidradenitis suppurativa: Table 1
- (2012) Ewout M Baerveldt et al. ANNALS OF THE RHEUMATIC DISEASES
- Canakinumab in a patient with juvenile Behçet's syndrome with refractory eye disease: Figure 1
- (2012) Serdal Ugurlu et al. ANNALS OF THE RHEUMATIC DISEASES
- Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study
- (2012) Georg Schett et al. ARTHRITIS AND RHEUMATISM
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
- (2012) J. C. Jennette et al. ARTHRITIS AND RHEUMATISM
- Results of Interferon Alpha-2a Therapy in Patients with Behcet's Disease
- (2012) F. Nilüfer Yalçindağ et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Behçet Disease-associated Uveitis Successfully Treated with Golimumab
- (2012) Marina Mesquida et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Adalimumab for the treatment of Behcet's disease: experience in 19 patients
- (2012) D. Perra et al. RHEUMATOLOGY
- Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study
- (2011) Ahmet Gül et al. ANNALS OF THE RHEUMATIC DISEASES
- New insights into the pathogenesis of Behçet's disease
- (2011) Marc Pineton de Chambrun et al. AUTOIMMUNITY REVIEWS
- Tocilizumab treatment for neuro-Behcet's disease, the first report
- (2011) Lee S. Shapiro et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease
- (2010) Christoph M. E. Deuter et al. ARTHRITIS AND RHEUMATISM
- Interferon therapy in rheumatic diseases: state-of-the-art 2010
- (2010) Ina Kötter et al. CURRENT OPINION IN RHEUMATOLOGY
- Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)
- (2010) Fereydoun DAVATCHI et al. International Journal of Rheumatic Diseases
- Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients
- (2010) Aikaterini Arida et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- CSF levels of cytokines in neuro-Behçet's disease
- (2009) A. Borhani Haghighi et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease
- (2009) Yelda Bilginer et al. CLINICAL RHEUMATOLOGY
- Low-dose natural human interferon-α lozenges in the treatment of Behçet's syndrome
- (2009) Hasan Kılıç et al. RHEUMATOLOGY
- EULAR recommendations for the management of Behcet disease
- (2008) G Hatemi et al. ANNALS OF THE RHEUMATIC DISEASES
- Infliximab for the treatment of Neuro-Behçet's disease: A case series and review of the literature
- (2008) Nicolò Pipitone et al. ARTHRITIS AND RHEUMATISM
- Interleukin-6 in neuro-Behçet’s disease: Association with disease subsets and long-term outcome
- (2008) Gülşen Akman-Demir et al. CYTOKINE
- Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil
- (2008) Piergiorgio Neri et al. INTERNATIONAL OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More